Nagoya City University - 1) Nivolumab (Genetical Recombination) 240 mg 24 ml 1 vial 234 vial 2) Infliximab (Genetical Recombination) 100 mg 1 vial 854 vial 3) Pembrolizumab (Genetical Recombination) 100 mg 4 ml 1 vial 192 vial 4) Ustekinumab (Genetical Recombination) 45 mg 1 syringe 109 syringe 5) Aflibercept (Genetical ...

This tender with title Nagoya City University - 1) Nivolumab (Genetical Recombination) 240 mg 24 ml 1 vial 234 vial 2) Infliximab (Genetical Recombination) 100 mg 1 vial 854 vial 3) Pembrolizumab (Genetical Recombination) 100 mg 4 ml 1 vial 192 vial 4) Ustekinumab (Genetical Recombination) 45 mg 1 syringe 109 syringe 5) Aflibercept (Genetical ... has been published on Bidding Source portal dated 04 May 2020 for the country of Japan. It has been categorized on Syringes. For similar tenders you can see tenders mentioned below of this page.